查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1630924

非侵入性冠状动脉影像市场规模、份额、趋势分析报告：按方式、最终用途、地区、细分预测，2025-2030 年

Non-invasive Coronary Imaging Market Size, Share & Trends Analysis Report By Modality, By End-use By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

非侵入性冠状动脉影像市场的成长和趋势：

根据 Grand View Research, Inc 的一份新报告，全球非侵入性冠状动脉成像市场规模预计到 2030 年将达到 5.968 亿美元，2025 年至 2030 年的复合年增长率为 6.6%。

这是由于快速诊断严重心臟疾病的需求、冠状动脉疾病导致的死亡人数的增加、人口老化以及避免侵入性冠状动脉成像併发症的需求所致。冠状动脉疾病是世界各地区的第一个死亡原因。根据美国疾病管制与美国中心的数据，CAD 目前影响 2,010 万成年人。 2020年，每10名65岁以上的老年患者中就有2名将死于CAD。

近年来，影像诊断技术的进步使得人们能够使用非侵入性影像诊断来评估冠状动脉疾病的存在、严重程度和预后。冠状动脉狭窄的解剖意义可以透过 SPECT/PET 等负荷心肌灌注造影或负荷 MRI 来确定，而冠状动脉 CT血管造影术或冠状动脉 MRI 将提供冠状动脉狭窄的解剖学评估。根据美国国家生物技术资讯中心（NCBI）发表的一项研究，CT血管造影术在检测CAD方面已显示出良好的效果。

对于检测 70% 狭窄的敏感度、特异度、阳性预测值 (PPV) 和阴性预测值 (NPV) 分别为 94%、83%、48% 和 99%。因此，CT血管摄影检查作为诊断严重冠状动脉疾病的有价值的工具显示出良好的效果。 NCBI 发表的另一项研究显示，非侵入性心臟磁振造影（MR）心臟超音波图检查更有前景。本研究比较了多巴酚丁胺负荷 CMR (DSMR) 和多巴酚丁胺负荷超音波心动图 (DSE) 在检测 CAD（≥50% 狭窄）方面的效果，以 ICA 作为黄金标准。因此，对于疑似患有 CAD 的患者，DSMR 的诊断准确性高于 DSE。

新冠疫情的爆发导致研究活动减少、大学和学术机构关闭、临床试验活动减少。由于担心病毒传播，最终使用地点的诊断和手术活动也减少了。医院、诊断中心和诊所的经济压力导致非侵入性诊断软体和系统的采用率下降。因此，疫情导致2020年市场萎缩。

非侵入性冠状动脉影像市场报告重点

  • 2024 年，超音波心臟检查领域占据市场主导地位，占有 33.1% 的份额。这项优势源自于成本效益、广泛可用性和非侵入性等因素，使其成为常规心血管评估的首选。
  • 2024 年，医院部门占据市场主导地位，份额为 42.6%。这是因为心血管疾病的发生率不断上升，导致去医院就诊的患者数量也随之增加。
  • 2024 年北美非侵入性冠状动脉影像市场占有最大份额，为 38%。这一优势主要归功于该地区主要市场参与者的存在及其加强影响力的战略努力。
  • 预测期内，亚太地区非侵入性冠状动脉成像市场预计将以 6.9% 的复合年增长率成长。这种快速成长很大程度上归功于中国、印度和日本等主要国家的医疗保健产业的扩张。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 非侵入性冠状动脉影像市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 非侵入性冠状动脉影像市场分析工具
    • 产业分析-波特五力分析
    • PESTEL 分析

第 4 章。

  • 细分仪表板
  • 全球非侵入性冠状动脉影像模式市场趋势分析
  • 2018 年至 2030 年全球非侵入性冠状动脉影像市场规模及趋势分析（按方式）
  • 放射性核种心臟显像
  • 心臟超音波图
  • 心臟CT
  • 心臟磁振造影

5. 非侵入性冠状动脉影像市场：最终用途估计与趋势分析

  • 细分仪表板
  • 全球非侵入性冠状动脉影像最终用途市场趋势分析
  • 2018 年至 2030 年全球非侵入性冠状动脉影像市场规模及趋势分析（依最终用途）
  • 医院
  • 诊断影像中心
  • 研究组织

6. 非侵入性冠状动脉影像市场：按模式、最终用途和地区进行的估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 市场规模、预测趋势分析，2018 年至 2030 年：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的近期趋势及影响分析
  • 公司/竞争对手分类
  • 2024 年主要企业的市场占有率分析
  • Company Position Analysis
  • 公司分类（新兴企业、创新企业、领导者）
  • 公司简介
    • GE HealthCare
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • Canon Medical Systems Corporation
    • Neusoft Medical Systems
    • United Imaging Healthcare
    • Esaote SpA
    • Fujifilm Holdings Corporation
    • Shimadzu Corporation
Product Code: GVR-4-68039-998-0

Non-invasive Coronary Imaging Market Growth & Trends:

The global non-invasive coronary imaging market size is expected to reach USD 596.8 million by 2030, registering a CAGR of 6.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Need to diagnose critical cardiac conditions in a short time span, increased deaths by coronary artery diseases, the growing geriatric population, and the growing need to avoid complications of invasive coronary imaging. Coronary artery disease is the leading cause of death in all regions across the globe. According to the Centers for Disease Control and Prevention, to date, 20.1 million adults have CAD. In 2020, 2 in every 10 geriatric patients above the age of 65, died due to CAD.

Non-invasive imaging has recently been utilized to assess the existence, severity, and prognosis of coronary artery disease as a result of advancements in imaging technology. The anatomical importance of coronary artery stenosis can be determined by stress myocardial perfusion imaging, such as SPECT/PET and stress MRI, whereas coronary CT angiography and MRI of the coronary arteries give anatomical assessments of coronary stenosis. Studies published in the National Center for Biotechnology Information (NCBI), stated that CT angiography showed promising results in the detection of CAD.

Its sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 94%, 83%, 48%, and 99%, respectively, to detect 70% stenosis. Thus, CT angiography shows promising results as a valuable tool for the diagnosis of significant coronary artery disease. Another research study published in NCBI shows promising results of noninvasive cardiac MR over echocardiography. The study compared dobutamine stress CMR (DSMR) with dobutamine stress echocardiography (DSE) in the detection of CAD (>=50% stenosis) using ICA as the gold standard. It resulted that, DSMR has higher diagnostic accuracy than that DSE in patients with suspected CAD.

The outbreak of the COVID-19 pandemic led to a decline in research activities, the closure of universities and academic institutions, and a decline in clinical trial activities. The fear of virus spread also declined any diagnostic or surgical activities at end-use settings. The economic crunch at hospitals, diagnostic centers, or clinics, led to the reduced adoption of software and systems for non-invasive diagnosis. Thus, the pandemic led to a decline in the market in 2020.

Non-invasive Coronary Imaging Market Report Highlights:

  • The Echocardiography segment dominated the market by capturing a share of 33.1% in 2024. This dominance can be attributed to factors such as its cost-effectiveness, widespread availability, and non-invasive nature, making it a preferred choice for routine cardiovascular assessments.
  • The hospital segment dominated the market by capturing a share of 42.6% in 2024. This is owing to the growing number of patient visits to hospitals, driven by the increasing prevalence of cardiovascular diseases.
  • North America non-invasive coronary imaging market held the largest share of 38% in 2024. This dominance is primarily attributed to the presence of major market players in the region and their strategic efforts to strengthen their presence.
  • Asia Pacific non-invasive coronary imaging market is expected to witness the fastest growth of CAGR 6.9% over the forecast period. This rapid growth is largely attributed to the expanding healthcare sectors in key countries such as China, India and Japan.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Non-invasive Coronary Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiac diseases
      • 3.2.1.2. Need for advancements diagnostic tools
      • 3.2.1.3. Increasing geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of reliable and guaranteed clinical trial data
      • 3.2.2.2. Complex regulatory environment
  • 3.3. Non-invasive Coronary Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Non-invasive Coronary Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Non-invasive Coronary Imaging Modality Market Movement Analysis
  • 4.3. Global Non-invasive Coronary Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. Radionuclide Cardiac Imaging
    • 4.4.1. Radionuclide cardiac imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Echocardiography
    • 4.5.1. Echocardiography market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Cardiac Computed Tomography
    • 4.6.1. Cardiac computed tomography market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Cardiac Magnetic Resonance Imaging
    • 4.7.1. Cardiac magnetic resonance imaging market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Non-invasive Coronary Imaging Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Non-invasive Coronary Imaging End Use Market Movement Analysis
  • 5.3. Global Non-invasive Coronary Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Diagnostic Imaging Centers
    • 5.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Research Institutes
    • 5.6.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Non-invasive Coronary Imaging Market: Regional Estimates & Trend Analysis By Modality, End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement structure
      • 6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement structure
      • 6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement structure
      • 6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement structure
      • 6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement structure
      • 6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement structure
      • 6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement structure
      • 6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement structure
      • 6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement structure
      • 6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement structure
      • 6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement structure
      • 6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement structure
      • 6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement structure
      • 6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement structure
      • 6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement structure
      • 6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement structure
      • 6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement structure
      • 6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement structure
      • 6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement structure
      • 6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement structure
      • 6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement structure
      • 6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement structure
      • 6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement structure
      • 6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2024
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 7.6. Company Profiles
    • 7.6.1. GE HealthCare
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. Koninklijke Philips N.V.
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Siemens Healthineers AG
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Canon Medical Systems Corporation
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Neusoft Medical Systems
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. United Imaging Healthcare
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. Esaote SpA
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Fujifilm Holdings Corporation
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Shimadzu Corporation
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America non-invasive coronary imaging market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 5 North America non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 7 U.S. non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 9 Canada non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 10 Mexico non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 11 Mexico non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe non-invasive coronary imaging market, By country, 2018 - 2030 (USD Million)
  • Table 13 Europe non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 14 Europe non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 15 UK non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 16 UK non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 18 Germany non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 19 France non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 20 France non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 22 Italy non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 23 Denmark non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 24 Denmark non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 25 Sweden non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 26 Sweden non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 28 Norway non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific non-invasive coronary imaging market, By country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 32 Japan non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 33 Japan non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 34 China non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 35 China non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 36 India non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 37 India non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 38 Australia non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 39 Australia non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 41 South Korea non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 43 Thailand non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 44 Latin America non-invasive coronary imaging market, By Country, 2018 - 2030 (USD Million)
  • Table 45 Latin America non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 46 Latin America non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 47 Brazil non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 48 Brazil non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 49 Argentina non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 50 Argentina non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa non-invasive coronary imaging market, By country, 2018 - 2030 (USD Million)
  • Table 52 Middle East & Africa non-invasive coronary imaging market, By modality, 2018 - 2030 (USD
  • Table 53 Middle East & Africa non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 54 South Africa non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 55 South Africa non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 58 UAE non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 59 UAE non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait non-invasive coronary imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 61 Kuwait non-invasive coronary imaging market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Non-Invasive Coronary Imaging market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Non-Invasive Coronary Imaging market driver impact
  • Fig. 19 Non-Invasive Coronary Imaging market restraint impact
  • Fig. 20 Non-Invasive Coronary Imaging market: Modality movement analysis
  • Fig. 21 Non-Invasive Coronary Imaging market: Modality outlook and key takeaways
  • Fig. 22 Radionuclide cardiac imaging market estimates and forecast, 2018 - 2030
  • Fig. 23 Echocardiography market estimates and forecast, 2018 - 2030
  • Fig. 24 Cardiac computed tomography market estimates and forecast, 2018 - 2030
  • Fig. 25 Cardiac magnetic resonance imaging market estimates and forecast, 2018 - 2030
  • Fig. 26 Non-Invasive Coronary Imaging market: End-use movement analysis
  • Fig. 27 Non-Invasive Coronary Imaging market: End-use outlook and key takeaways
  • Fig. 28 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 29 Diagnostic imaging centers market estimates and forecast, 2018 - 2030
  • Fig. 30 Research institutes market estimates and forecast, 2018 - 2030
  • Fig. 31 Global non-invasive coronary imaging market: Regional movement analysis
  • Fig. 32 Global non-invasive coronary imaging market: Regional outlook and key takeaways
  • Fig. 33 North America
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030
  • Fig. 35 U.S.
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 37 Canada
  • Fig. 38 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 39 Mexico
  • Fig. 40 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 41 Europe
  • Fig. 42 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 43 UK
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030
  • Fig. 45 Germany
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 47 France
  • Fig. 48 France market estimates and forecasts, 2018 - 2030
  • Fig. 49 Italy
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 51 Spain
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 53 Denmark
  • Fig. 54 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 55 Sweden
  • Fig. 56 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 57 Norway
  • Fig. 58 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 59 Asia Pacific
  • Fig. 60 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 61 China
  • Fig. 62 China market estimates and forecasts, 2018 - 2030
  • Fig. 63 Japan
  • Fig. 64 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 65 India
  • Fig. 66 India market estimates and forecasts, 2018 - 2030
  • Fig. 67 Thailand
  • Fig. 68 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 69 South Korea
  • Fig. 70 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 71 Australia
  • Fig. 72 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 73 Latin America
  • Fig. 74 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 75 Brazil
  • Fig. 76 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 77 Argentina
  • Fig. 78 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 79 Middle East and Africa
  • Fig. 80 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 81 South Africa
  • Fig. 82 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 83 Saudi Arabia
  • Fig. 84 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 85 UAE
  • Fig. 86 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 87 Kuwait
  • Fig. 88 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 89 Market share of key market players- Non-Invasive Coronary Imaging market